Cargando…

PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation

Colorectal cancer (CRC) growth and progression is frequently driven by RAS pathway activation through upstream growth factor receptor activation or through mutational activation of KRAS or BRAF. Here we describe an additional mechanism by which the RAS pathway may be modulated in CRC. PTPRS, a recep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Thomas B., Yang, Mingli, Schell, Michael J., Wang, Heiman, Ma, Le, Pledger, W. Jack, Yeatman, Timothy J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006154/ https://www.ncbi.nlm.nih.gov/pubmed/29915291 http://dx.doi.org/10.1038/s41598-018-27584-x

Ejemplares similares

PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC
por: Davis, Thomas B., et al.
Publicado: (2019)

Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer
por: Davis, Thomas Benjamin, et al.
Publicado: (2022)

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy
por: Yang, Mingli, et al.
Publicado: (2022)

APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes
por: Thota, Ramya, et al.
Publicado: (2021)

Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer
por: Omolo, Bernard, et al.
Publicado: (2016)

High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma
por: Lertpanprom, Muntinee, et al.
Publicado: (2022)

Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era
por: Kim, Richard, et al.
Publicado: (2015)

Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer
por: Maik-Rachline, Galia, et al.
Publicado: (2019)

SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation
por: Erazo, Tatiana, et al.
Publicado: (2020)

Bim Nuclear Translocation and Inactivation by Viral Interferon Regulatory Factor
por: Choi, Young Bong, et al.
Publicado: (2010)

RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball
por: Herrero, Ana, et al.
Publicado: (2021)

Nuclear translocation of beta-catenin in colorectal cancer
por: Kobayashi, M, et al.
Publicado: (2000)

Integrin-Mediated Adhesion Regulates ERK Nuclear Translocation and Phosphorylation of Elk-1
por: Aplin, Andrew E., et al.
Publicado: (2001)

Targeting Cadherin-17 Inactivates Ras/Raf/MEK/ERK Signaling and Inhibits Cell Proliferation in Gastric Cancer
por: Lin, Zhaohu, et al.
Publicado: (2014)

Bim nuclear translocation and inactivation by HHV-8 interferon regulatory factor 1
por: Choi, Young, et al.
Publicado: (2010)

A computationally engineered RAS rheostat reveals RAS/ERK signaling dynamics
por: Rose, John C., et al.
Publicado: (2016)

Prevention of Wogonin on Colorectal Cancer Tumorigenesis by Regulating p53 Nuclear Translocation
por: Feng, Qian, et al.
Publicado: (2018)

MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma
por: Fu, Dechen, et al.
Publicado: (2022)

Regulation of cell proliferation by ERK and signal-dependent nuclear translocation of ERK is dependent on Tm5NM1-containing actin filaments
por: Schevzov, Galina, et al.
Publicado: (2015)

ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
por: Yang, Weiwei, et al.
Publicado: (2012)

Conversion of graded phosphorylation into switch-like nuclear translocation via autoregulatory mechanisms in ERK signalling
por: Shindo, Yuki, et al.
Publicado: (2016)

ERK-mediated phosphorylation of BIS regulates nuclear translocation of HSF1 under oxidative stress
por: Kim, Hye Yun, et al.
Publicado: (2016)

Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells
por: Arafeh, Rand, et al.
Publicado: (2017)

IRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of β-catenin
por: Tian, Miao, et al.
Publicado: (2020)

Whole Genome Sequencing Analysis of a Stage IV Colon Cancer Patient with a 10-Year Disease-Free Survival following Systemic Chemotherapy/Bevacizumab
por: Yeatman, Timothy J., et al.
Publicado: (2018)

Uncoupling of EGFR–RAS signaling and nuclear localization of YBX1 in colorectal cancer
por: Roßner, F, et al.
Publicado: (2016)

CARD9 mediates Dectin-1–induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity
por: Jia, Xin-Ming, et al.
Publicado: (2014)

A novel domain of caveolin-2 that controls nuclear targeting: regulation of insulin-specific ERK activation and nuclear translocation by caveolin-2
por: Kwon, Hayeong, et al.
Publicado: (2011)

Cordyceps militaris Grown on Germinated Soybean Suppresses KRAS-Driven Colorectal Cancer by Inhibiting the RAS/ERK Pathway
por: Seo, HeeJung, et al.
Publicado: (2018)

Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa
por: Jafari, Meryem, et al.
Publicado: (2022)

Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells
por: Arafeh, Rand, et al.
Publicado: (2019)

UBE2T promotes β‐catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK‐dependent activation
por: Lioulia, Elisavet, et al.
Publicado: (2022)

A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
por: Schell, Michael J., et al.
Publicado: (2016)

Ras–ERK Signaling in Behavior: Old Questions and New Perspectives
por: Fasano, Stefania, et al.
Publicado: (2011)

Author Correction: IRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of β-catenin
por: Tian, Miao, et al.
Publicado: (2023)

Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer
por: Xu, Xiaojing, et al.
Publicado: (2023)

Mulberry polyphenol extracts attenuated senescence through inhibition of Ras/ERK via promoting Ras degradation in VSMC
por: Chen, Ching-Pei, et al.
Publicado: (2022)

Cutting the Brakes on Ras—Cytoplasmic GAPs as Targets of Inactivation in Cancer
por: Bellazzo, Arianna, et al.
Publicado: (2020)

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
por: Catalano, Antonella, et al.
Publicado: (2021)

The metastasis suppressor Nm23 as a modulator of Ras/ERK signaling
por: Takács-Vellai, Krisztina
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fi2hgidth8ona02il0sc16fiec